Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Philip Lim

Diagnostic Radiology Danville, PA Medical Doctor

NPI 1144218702 CMS profile 324459

100 N Academy Ave, Danville, PA 17822

Open in the dashboard

General payments

$879,311

498 records reported · program years 2019–2025

Research payments

$637,914

Paid to them · 53 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$7,480 paid to institutions, not to them · program year 2025

Through program year 2025, Philip Lim of Danville, PA is reported in the CMS Open Payments database as having received $879,311 across 498 general payments and $637,914 in research payments paid to them. Separately, studies naming them as principal investigator received $7,480 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $175,889 16
2025 Research $40 1
2024 General $47,280 7
2024 Research $10,420 6
2023 General $60,197 11
2023 Research $2,145 1
2022 General $31,321 10
2021 General $174,938 145
2021 Research $176,465 15
2020 General $190,658 158
2020 Research $226,775 15
2019 General $199,028 151
2019 Research $222,069 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Philip Lim
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Philip Lim were reported at $175,889. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Philip Lim Diagnostic Radiology median Middle half National median
2019 $199,028 $108 $29–$318 $163
2020 $190,658 $65 $21–$252 $114
2021 $174,938 $92 $24–$292 $132
2022 $31,321 $104 $29–$294 $149
2023 $60,197 $110 $29–$337 $160
2024 $47,280 $113 $30–$356 $164
2025 $175,889 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $525,335 440 payments
  2. Janssen Research & Development, LLC $295,262 24 payments
  3. Seattle Genetics, Inc. $42,520 9 payments
  4. Boehringer Ingelheim International GmbH $8,993 7 payments
  5. Siemens Medical Solutions USA, Inc. $5,046 6 payments
  6. Vital Images, Inc. $1,000 2 payments
  7. Pfizer Inc. $740 1 payment
  8. Ge Healthcare $143 4 payments
  9. HeartFlow, Inc. $129 1 payment
  10. Canon Medical Systems USA, Inc. $62 1 payment
  11. Other $81 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $873,849 483 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,990 2 payments
  3. Honoraria $1,000 2 payments
  4. Food and Beverage $442 10 payments
  5. Travel and Lodging $30 1 payment
Products named General payments · program years 2019–2025
  1. KEYTRUDA $516,770 428 payments
  2. ERLEADA $295,262 24 payments
  3. Vitrea Advanced Visualization $1,000 2 payments
  4. MK-7339 $570 4 payments
  5. Mammomat Revelation $530 2 payments
  6. Mammomat Inspiration $500 1 payment
  7. FFRct $129 1 payment
  8. INTERVENTIONAL ANGIOGRAPHY SYSTEM $62 1 payment
  9. ISOVUE $51 1 payment
  10. Lumason $51 1 payment
  11. Other $106 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. E.R. Squibb & Sons, L.L.C. $625,309 45 payments
  2. Boehringer Ingelheim International GmbH $6,295 2 payments
  3. Regeneron Pharmaceuticals, Inc. $5,800 3 payments
  4. BioMarin Pharmaceutical Inc. $510 3 payments

Billing to Medicare

Part B · data year 2024 · 186 billing codes

Paid by Medicare

$149,786

Medicare's payments for the services billed

Medicare patients

3,661

Average age 75

Services billed

5,236

2,597 women, 1,064 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Ischemic heart disease 33%
Diabetes 31%
Osteoporosis 31%
Chronic kidney disease 29%
Depression 27%
Atrial fibrillation 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ERLEADA
  • Janssen Research & Development, LLC $45,540
$45,540 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

551 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record